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Abstract
Breast cancer (BC) is a growing public health concern in most developed and developing countries. Since an increasing number of patients with
BC are diagnosed before the menopause and premenopausal women show a more aggressive phenotype, there is consistent interest in
promoting prevention strategies in order to reduce the incidence of BC in the premenopause. The Mediterranean diet (MD) has been reported
to have beneficial effect in terms of cancer prevention. This healthy dietary pattern consists primarily of foods having important antioxidant
properties along with a favourable fatty acid profile, all associated with a reduced risk of cancer. Due to the large variability in study subject
characteristics, the protective role of the MD on BC still remains controversial and studies that have investigated the association between
adherence to the MD and risk of BC in premenopausal women are fewer than those in postmenopausal women. In addition, the possibility
that the beneficial effects of the MD are due to a single component or might more probably derive from the synergic effects of all components
of the MD remains a scantly explored field. Considering the increased risk of recurrence and mortality rate of BC in premenopausal women as
compared with postmenopausal women, the aim of the present report is to provide a general overview of the current evidence on the relation-
ship between BC and the MD specifically in premenopausal women, and to emphasise the potential role of the MD as an effective measure to
reduce the risk of developing BC in premenopausal women.
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Introduction
Breast cancer (BC) is a growing public health problem. Despite
the current efforts in preventing BC, its incidence is increasing in
most developed and developing countries(1–4). Approximately
1·4 million new cases of BC are diagnosed worldwide each year,
with a mortality rate of about 450 000 per year(5). The risk factors
for BC include age, genetic mutations (BRCA1 and BRCA2)(6),
younger age at menarche, nulliparity, first pregnancy after the
age of 30 years, older age at menopause, dense breast tissue(7),
hormone replacement therapy, use of oral contraceptives(8) and
personal and family history of BC or other breast diseases(9). In
this complex scenario, it is of fundamental importance to evalu-
ate accurately the role of modifiable risk factors, such as nutri-
tion. Although BC is generally considered an age-dependent
disease, nearly 7 % of BC is diagnosed in premenopausal
women under 40 years of age(10), while another 3 and 0·65 %
concern women less than 35 years and less than 30 years of
age, respectively(11–14). Although with some discrepancies,
BC in premenopausal women is generally more aggressive
than in postmenopausal women, showing higher histological
grading, increased proliferation rate, higher rates of vascular
invasion(15), and a higher proportion of triple-negative BC(9).
Consistently, the presence of an extensive intraductal component
as adjunctive risk factor for BC recurrence in premenopausal
women has been associated with an increased risk of recurrence
and mortality rate compared with postmenopausal women(16,17).
Furthermore, hormone treatment seems to be significantly less
efficacious in premenopausal women and the presence in BC
of endocrine receptors, including oestrogen receptors (ERα,
ERβ) and progesterone receptor (PR), human epidermal growth
factor receptor 2 (HER-2) and proliferation markers are signifi-
cantly different in women ≤ 45 years compared with those
≥ 65 years of age(18). The incidence of BC among premenopausal
women is increasing(19) and represents a significant issue in
developing countries because more than 20% of BC cases and
more than 20% of deaths occur in women aged 45 years, in con-
trast to developed countries where these figures correspond to
less than 12% and 10 %, respectively(19,20). This increase in BC
among premenopausal women is not exclusively attributable to
an increase in life expectancy, but rather to several environmental
Abbreviations: BC, breast cancer; COX, cyclo-oxygenase; ER, oestrogen receptor; HER-2, human epidermal growth factor receptor 2; HR, hazard ratio;
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risk factors and unhealthy lifestyles, such as unbalanced diets, lack
of exercise and use of alcohol and tobacco(21). The World Cancer
Research Fund (WCRF) in 2018 reported that choosing healthier
lifestyles could prevent 4 million cases of cancer around the
world(22,23), 30% of which by simply adopting healthy dietary
habits(24). Notwithstanding the benefits of single nutrients, the
dietary pattern as a whole may allow us to better capture the
complex inter-relationships between dietary components and
represents a more adequate approach toward understanding
the relationship between diet and cancer(25). Despite cancer
prevention through dietary and lifestyle choices having been
identified as a future cancer research priority(26), evidence on a
specific healthy dietary pattern, such as the Mediterranean diet
(MD), is limited and weak(23). In particular, no consistent pattern
of association between the MD and BC in both pre- and postme-
nopausal women emerged in the WCRF report. However, the
vast majority of the studies included in this report were conducted
in non-Mediterranean settings, where a high variability in the
compliance with the MD is very likely, and were not specifically
conducted in premenopausal women. Thus, the relationship of
the MD with BC in premenopausal women still remains an open
issue. The aims of the present report are to provide a general
overview of the updated evidence on the association of BC and
adherence to the MD specifically in premenopausal women,
and to emphasise the potential role of the MD and its principal
components as an effective measure in the prevention of BC in
premenopausal women.
The Mediterranean diet
Although limited by a large variability in study subject character-
istics, type and length of interventions, selected end-points and
statistical analysis, several epidemiological and clinical studies
strongly support the association between nutritional factors
and the development or progression of cancer, including
BC(27–30). As is it well known, the MD has long been considered
as the utmost example of a healthy, well-balanced diet. The term
‘Mediterranean diet’ was originally coined by Ancel Keys, but its
definitions may vary across different settings and it is actually
difficult to describe in detail a Mediterranean dietary pattern
and its components. Indeed, there are many different
‘Mediterranean diets’, based on cultural, ethnical, religious and
economical differences existing among the various populations
and countries situated along the Mediterranean basin(31).
However, different MD models do generally share some impor-
tant characteristics; specifically, they all have an abundant
plant-based food content, such as fruits and vegetables, whole
grains, legumes and nuts, including olive oil as the main source
of monounsaturated fats; they are all characterised by a limited
intake of red andprocessed meat, saturated fat and refined sugars,
low-to-moderate intake of low-fat dairy products and moderate
consumption of fish, while a regular, but moderate, alcohol
(mostly red wine) consumption with meals is emphasised(32,33).
The main components of a MD, such as fruits and vegetables,
fibres, olive oil, fish and red wine, are rich sources of several
bioactive compounds, including antioxidants (i.e. carotenoids,
flavonoids, resveratrol and other polyphenolic compounds)(34,35)
and n-3 PUFA. In summary, a Mediterranean dietary pattern tends
towards a moderate content in total fats (32–35% of total energy),
a relatively low content in saturated fat (9–10% of total energy), a
relatively high quantity of fibres (27–37 g/d) andn-3 PUFA(36). This
type of diet has been widely studied and several studies
have reported a protective effect against various chronic diseases
and cancers, including BC(37) and theMDmaywell be identified as
a promising approach for preventing BC(38). Besides the potential
role exerted by the anti-inflammatory properties of food antioxi-
dants on overall incidence of cancer, more specifically BC(39),
Carruba et al.(40) illustrated that a traditional MD in healthy
postmenopausal women may reduce the risk of developing BC
also because of its effects on the metabolism of endogenous
oestrogens. Adherence to the MD has been extensively evaluated
by different standardised indexes(41–43). However, there is no
objective method to measure MD adherence, nor are there
commonly accepted criteria to evaluate the indexes(44). To date,
one of the most frequently used is the MD score proposed by
Trichopoulou et al.(45,46). This index is based on nine dietary com-
ponents and the method consists of assigning a value of 0 or 1 to
each component, depending or food groups and on food servings
per meal, day, and week, with a median as cut-off point. In
particular, for components typical of the MD (i.e. fruits and nuts,
vegetables, legumes, cereals, fish and seafood, high monounsatu-
rated:saturated dietary lipid ratio, mainly olive oil, and regular but
moderate intake of ethanol, red wine) is attributed a value of 1 for
an intake greater or equal to the sex-specificmedian,while a value
of 0 is attributed in case of intake lower than the median.
Conversely, for components that are not typical of theMD(namely
redmeats), a valueof 1 or 0 is given for a consumption less ormore
than the sex-specific median, respectively. Thus, the total MD
score ranges from 0 (minimal adherence to the traditional MD)
to 9 (maximal adherence)(46).
Data sources and searches
A literature search was performed using the electronic data-
bases PubMed (August 2018) and Scopus (August 2018). The
search strategy for PubMed was: (‘Mediterranean diet’ or
‘Mediterranean’ or ‘diet’ or ‘dietary pattern’ or ‘dietary adher-
ence’) and (‘breast cancer’) and (‘prospective’ or ‘follow-up’ or
‘cohort’ or ‘longitudinal’) and (‘premenopausal women’). The
search strategy had language restrictions; only the documents
in English have been taken into consideration. Moreover, refer-
ence lists from reviews, meta-analyses and the retrieved articles
were searched to identify further relevant studies. The literature
search was conducted by one author (D. L.), with questions or
uncertainties resolved by discussion with another author (S. S.).
Cohort studies and case–control studies investigating the associ-
ation between the MD and risk of BC incidence in the premeno-
pausal female population were selected.
Breast cancer in premenopausal women and the
Mediterranean diet: cohort studies and case–control
studies
Studies that have investigated the association between adher-
ence to the MD and risk of BC in premenopausal women are
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fewer than those in postmenopausal women(23). It should also be
considered that, although postmenopausal women are at a
higher risk for BC development than younger women, BC during
pre-menopause seems to be more aggressive than in postmeno-
pause. Some of the epidemiological evidence available
suggested that a MD could reduce the risk of BC(34,38). As men-
tioned above, an inconsistent pattern of association between the
MD and BC in both pre- and postmenopausal women emerged
in the more recent WCRF report(23). Of interest, considering the
strict relationship between theMD, BMI and glucosemetabolism
on one side(47–49), and BMI and BC on the other side(50), the
association between the MD and BC remained significant also
after adjusting or stratifying data for common confounding
variables, including BMI and body fatness. However, the associ-
ation between the MD and BC is more evident for postmeno-
pausal women than in premenopausal women. In fact, for
premenopausal women the results are still conflicting(23).
Nevertheless, other studies that considered specific cancer
subgroups defined by hormone receptor status(34,51–53) or
menopausal status did not confirm such observation(54–56).
Trichopoulou et al.(38) evaluated in a cohort study the relation-
ship between conformity and adherence to an MD and BC risk
within the European Prospective Investigation into Cancer and
Nutrition (EPIC) cohort in Greece(38). The sample population
used for this analysis consisted of 14 807 women, of which
240 with incident BC, with a follow-up period of approximately
9 years. Increasing conformity to theMDwas not associatedwith
a lower BC risk in the entire cohort (hazard ratio (HR) 0·88
for every 2 points; 95 % CI 0·75, 1·03) or in premenopausal
women (HR 1·01 for every 2 points; 95 % CI 0·80, 1·28), but there
was a marginally significant inverse association among postme-
nopausal women (HR 0·78 for every 2 points; 95 % CI 0·62, 0·98;
P for interaction by menopausal status= 0·05). However, in this
studymenopausal status was ascertained at enrolment and not at
the time of diagnosis of cancer, which is likely to have introduced
some sort of misclassification(38). In a cohort study, Cade et al.(56)
evaluated the risk of developing BC associated with consump-
tion of two common dietary patterns: a Mediterranean dietary
pattern and a dietary pattern conforming to the WHO Healthy
Diet Index; the study population included 828 incident cases
of BC in 33 731 women, with a mean follow-up of 9 years(56).
The compliance to the diet was assessed at baseline using a
219-item self-administered FFQ. This study evidenced that in
premenopausal, but not postmenopausal, women, there was a
not significant inverse association with an increasing adherence
to the MD pattern, but the maximal adherence to the MD was
associated with a HR of 0·65 (95 % CI 0·42, 1·02; Ptrend= 0·09)
compared with minimal adherence. Although based on a large
sample size, the results of this study were limited by the fact that
lifestyle questionnaires were self-filled by the participants in the
study(56). In another cohort study, Couto et al.(54) investigated the
association between the MD and BC risk in pre- and post-
menopausal women, aged 30–49 years, within a span of 16
years(54). Adherence to the MD pattern was not associated with
an overall decrease in BC risk or with specific BC characteristics
in both pre- and postmenopausal women. However, women
that reported a higher adherence to the MD also presented
higher risk factors for BC (family history of BC, use of oral
contraceptives or postmenopausal hormone therapy, higher
alcohol consumption), whichmight have probably counteracted
the beneficial effect of the MD(54). In another prospective cohort
study, Buckland et al.(34) evaluated the association between
adherence to the MD and risk of BC among 335 062 women
recruited from 1992 to 2000 in ten European countries, and
followed for 11 years on average(34). Adherence to the MD
was assessed using a semi‐quantitative FFQ administered
through a personal interview. The results showed that a higher
adherence to the MD was associated with a lower risk of BC in
postmenopausal women only, mainly in ER−/PR− tumours,
while this association was not consistent in premenopausal
women. However, the results of this study should be interpreted
with caution as a similar weight was given to each component
and the foods, with the assumption that they have equivalent
effects on BC risk. Similarly, a meta-analysis of only cohort
studies by van den Brandt & Schulpen(51) focusing on post-
menopausal BC did not show a significant inverse association
between overall postmenopausal BC and high adherence to
the MD, although the HR estimate of 0·94 was marginally
significant. A very recent meta-analysis on primary prevention
of overall cancer risk including eighty-three studies indicated
an inverse association of adherence to the MD with cancer
mortality and risk of BC among postmenopausal women, but not
among premenopausal women (pooled relative risk (RR) 1·3)(57).
In a case–control study, Castello et al.(58) evaluated the
association between dietary patterns and risk of BC in Spanish
women, stratifying the sample bymenopausal status and tumour
subtype. The authors recruited 1017 incident BC cases and 1017
matched healthy controls without a history of BC(58). Cases and
controls completed a structured questionnaire collecting infor-
mation on demographic and anthropometric measurements,
personal and family history, past physical activity and diet and
menopausal status. In this study three food models were consid-
ered: the Western pattern, characterised by high intakes of fatty
and sugary products and red and processed meat; the prudent
pattern, characterised by high intakes of low-fat dairy products,
vegetables, fruits, whole grains and juices; Mediterranean dietary
patterns. Adherence to the Western dietary pattern was associ-
ated with a higher risk of BC (OR for the top v. the bottom
quartile 1·46; 95 % CI 1·06, 2·01; P= 0·02), especially in preme-
nopausal women (OR 1·75; 95 % CI 1·14, 2·67; P= 0·01).
Conversely, the Mediterranean pattern was associated with a
lower risk of BC (OR 4th v. 1st quartile 0·56; 95% CI 0·40, 0·79;
P< 0·01). Although the detrimental effect of the Western pattern
was equally observed in all tumour subtypes, the protective effect
of the Mediterranean pattern was stronger for triple-negative BC
(OR 0·32; 95% CI 0·15, 0·66; P= 0·04). Finally, no association
was found between adherence to the prudent pattern and the
BC risk(58). Subsequently a multicase–control study by Castello
et al.(59) confirmed these data. The objective of this study was
to externally validate the effect of the three food models on BC
risk, as reported in a previous study (EpiGEICAMstudy)(59). A high
adherence to the Western diet resulted in an increased BC risk
in both postmenopausal women (OR 4th v.1st quartile 1·48;
95% CI 1·07, 2·05; OR1SD-increase 1·14; 95% CI 1·01, 1·29) and
premenopausal women (OR 4th v. 1st quartile 1·68; 95% CI
1·02, 2·79; OR1SD-increase 1·19; 95% CI 1·02, 1·40), while a greater
Breast cancer and Mediterranean diet 3
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0954422419000167
Downloaded from https://www.cambridge.org/core. dipartimento di medicina clinica e sperimentale, on 28 Oct 2019 at 17:50:40, subject to the Cambridge Core terms of use, available at
adherence to the Mediterranean pattern seemed to afford
protection only in postmenopausal women, although this
protective effect did not reach statistical significance(59). Another
case–control study by Murtaugh et al.(60) evaluating the associa-
tions of dietary patterns (Western, prudent, Native Mexican,
Mediterranean, and dieter) with risk for BC confirmed a significant
protective role of theMDon incidence of BC in bothHispanic and
non-Hispanic women. These cases had a histologically confirmed
diagnosis for either in situ or invasive BC. Controls were healthy
women frequency-matched for ethnicity, BMI and menopausal
status. Food intake was reported by using a computerised,
interviewer-administered dietary history questionnaire(60). The
Western and prudent dietary patterns were associated with
greater risk of BC (OR 4th v. 1st quartile 1·32; 95% CI 1·04, 168;
P< 0·01; OR 4th v. 1st quartile 1·42; 95% CI 1·14, 1·77;
P< 0·01), and the Native Mexican and MD patterns were associ-
atedwith lower risk of BC (OR 4th v. 1st quartile 0·68; 95 %CI 0·55,
0·85; P< 0·01; OR 4th v. 1st quartile 0·76; 95% CI 0·63, 0·92;
P< 0·01)(60). In a very recent study, Turati et al.(61) investigated
the association between adherence to the MD and BC risk in a
case–control study conducted in Italy and Switzerland. This
analysis included 3034 BC cases and 3392 controls. Information
on dietary habits before diagnosis (for cases) or hospital admis-
sion (for controls) was based on a validated and reproducible
FFQ, and conformity to the traditional MD was assessed
through MD score. The Mediterranean dietary pattern was
associated with a reduced risk of BC. In particular, women with
the highest level of adherence to the MD reported an approx-
imately 20 % decrease in risk compared with women with the
lowest adherence. As far as the MD score is concerned, a score
of 0–3 was associated with OR for BC of 0·86 (95 % CI 0·76,
0·98), 0·82 for a MD score of 4–5 (95 % CI 0·71, 0·95) and
0·95 for a MD score of 6–9 (95 CI % 0·92, 0·99) with a signiﬁcant
downward trend of BC risk (P= 0·008). The exclusion of the
alcohol component from the MD score did not materially
modify the OR (OR 0·81; 95% CI 0·70, 0·95, for MD score ≥ 6).
Of interest, pre- and postmenopausal women reported almost
the same results(61). Although encouraging, the global examina-
tion of these results on the protective effect of theMD on BC still
remains controversial, as reported in Table 1, and did not shed
light upon the possibility that the beneficial effects are due to a
single component or to the synergic effects of all components
of the MD.
Breast cancer in premenopausalwomen and the
Mediterranean diet: components
Fruit and vegetables
There is limited/suggestive evidence that intake of fruit and
vegetables is inversely associated with BC risk in ER– BC(62,63).
Fruit and vegetable intake could represent a protective factor
on BC due to high concentrations of bioactive components, such
as carotenoids and polyphenols, substances with antioxidant
and anti-inflammatory properties(64,65).
Carotenoids. Carotenoids are a family of pigmented com-
pounds present in fruits and vegetables, which may protect Ta
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against DNA damage by neutralising reactive oxygen species
(ROS)(66) and activating the antioxidant response element
transcription system(67). In fact, carotenoids act as scavengers
of ROS and peroxyl radicals(68). Carotenoids can neutralise
radicals by different mechanisms: electron transfer, hydrogen
abstraction and hydrogen addition. Due to the presence of
conjugated double bonds, carotenoids can accept electrons from
ROS, thus neutralising free radicals(69). In addition to their
antioxidant action, carotenoids also have anti-proliferative
and pro-apoptotic actions; in an in vitro study, Gloria et al.(70)
incubated human breast adenocarcinoma cell lines (MCF-7,
MDA-MB-231 and MDA-MB-235) with lycopene and β-carotene
(0·5–10 μM) for 48 and 96 h. After 96 h of treatment, lycopene
significantly changed the cell viability in all cell lines.
Lycopene treatment inhibited cell viability of MCF-7 and
MDA-MB-235 cells by 30 and 20 %, respectively, while MDA-
MB-231 cells were inhibited up to 75 %, showing the best
response after 48 h, with a reduction of 30 %. After 48 h of treat-
ment, β-carotene caused significant changes in cell viability of
the three cell lines. The reduction was in the order of 40 %
in the MCF-7 cell line, 30 % in MDA-MB-235 cells and 70 % in
MDA-MB-231 cells. Furthermore, this study showed that
lycopene increased the percentage of cells in the G0/G1 phase
in the MCF-7 and MDA-MB-235 lines and also decreased the
percentage of cells in the G2/M phase, thus highlighting the role
of carotenoids as potential anti-tumour agents because of their
ability to arrest cell proliferation and to induce apoptosis(71,72).
Polyphenols. Polyphenols present in fruit and vegetables have
a wide range of biological functions(73). Antioxidant activity is
one of the key mechanisms that contributes to their protective
effect against oxidative damage. Polyphenols are able to scav-
enge a broad spectrum of highly reactive species, such as
ROS, oxidative N species, chlorine species, peroxynitrous acid
(ONOOH) and hypochlorous acid (HClO); they also block the
chain reactions of lipid peroxidation (chain breakers)(73).
Furthermore, polyphenols are involved in the reduction of the
Fenton reaction, by chelation of Fe, thus protecting cells from
oxidation from reactive hydroxyl radicals(74). Moreover, the
anti-cancer action of polyphenols might also be due to their
anti-inflammatory activity, as they block the up-regulation of
NF-κB, inhibit the phosphorylation and/or proteasomal degra-
dation of IκB, inhibit the liberation of NF-κB dimers from the
cytoplasm into the nucleus, and its interaction with target
DNA sequences(75,76). Another function of polyphenols is
modulation of apoptosis. Chou et al.(77) incubated human breast
adenocarcinoma cell lines MCF-7 with quercetin for 24 and 48 h
and at various doses (10–175 μM), resulting in an approximate
90·25 % decrease in viable cells. Quercetin caused a remarkable
increase in the number of S phase (14·56 to 61·35 %) and sub-G1
phase cells (0·1 to 8·32 %) in a dose- and time-dependent
manner. Following incubation with quercetin for 48 h, MCF-7
cells showed apoptotic cell death, with a reduction in mitochon-
drial membrane potential, down-regulation of Bcl-2 protein and
activation of the initiator caspases, caspase-8 and caspase-9, and
the effector caspase, caspase-6, probably due to the binding of
quercetin to the Fas/CD95 receptor(77). Besides, some groups of
flavonoids (the largest category of the polyphenols) act as a
phyto-oestrogen and their anti-cancer action can be ascribed
to their property of inhibiting aromatase activity(78). In particular,
there is a similarity between the A and C rings of flavonoids
with the D and C rings of androstenedione, the substrate of
aromatase(79). In addition, flavones and isoflavones bind to
oestrogen receptors (ER) and to the active sites of aromatase,
thus influencing the promoter activity of aromatase(80,81).
Cohort studies and case–control studies. In a prospective
cohort study, the association between fruit and vegetable intake
and BC risk was evaluated in 47 289 Japanesewomen(82). During
an average of 10·2 years of follow-up, 452 new cases of BC were
diagnosed. Cruciferous vegetable intake was associated with a
statistically significant decrease in the risk of premenopausal
BC (RR 4th v. 1st quartile 0·64; 95 % CI 0·38, 1·10; P= 0·046), with
a marginal inverse association with ER+/PR+ tumours (RR per
100 g increment 0·64; 95 % CI 0·41, 1·00)(82); in addition, a
positive association was observed between both total intake
of fruits and citrus fruits and BC risk in post- and premenopausal
women(82). Nevertheless, the bias in this study was the contem-
porary supplementary vitamin C intake and an extremely high
intake of citrus fruit might lead to an increased risk of BC due
to the extremely high dose of vitamin C(82). Recently, Fervid
et al.(83) evaluated the association between fruit and vegetable
intake during adolescence and early adulthood and risk of BC
in a cohort study including 90 476women. The study participants
completed a supplemental FFQ during high school (age range
13–18 years). During a follow-up of 22 years, a questionnaire
was administered every 2 years, which allowed documentation
of 3235 cases of invasive BC. A higher total fruit intake during
adolescence was associated with a lower risk of premenopausal
BC (HR 4th v. 1st quartile 0·75; 95 % CI 0·62, 0·90; P= 0·01).
A high early adulthood intake of fruits and vegetables rich in
α-carotene during early adulthood was also associated with a
lower risk of premenopausal BC (HR 0·82; 95 % CI 0·70, 0·96)
in those subjects in the highest quintile (median intake 0·5
servings/d) compared with those in the lowest quintile (median
intake 0·03 servings/d)(83).
Whole grains
Evidence on the inverse association between intake of whole
grains and BC risk still remains limited/inconclusive(84,85). The
protective action of whole grains is attributable to a high content
of fibres and it has also been suggested that soluble and insoluble
subtypes of dietary fibres may play a different role in the path-
ophysiological processes related to BC risk. Soluble fibres exert a
protective role in the development of BC through various mech-
anisms, such as the insulin growth factor (IGF) pathway(86). In
particular, it has been reported that soluble fibres reduce the
bioactivity of IGF-1, a major determinant in the pathogenesis
and progression of a number of different cancers, notably by
increasing IGF binding protein 3 (IGFBP3) concentration(87,88).
In addition, soluble fibres represent an effective controller of
glucose and insulin homeostasis by slowing down glucose
absorption, reducing insulin secretion and regulating the
bioavailability of IGF. Instead, insoluble fibres, mainly found
in seeds and whole grains, may help by down-regulating the
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enterohepatic cycling of oestrogens with the consequent
increase in their faecal excretion and decrease in their blood
concentrations(89). Moreover, fibres, especially soluble fibres,
reduce inflammation as their fermentation in the colon produces
SCFA that may exert an anti-inflammatory role(90–92) once
penetrated into the bloodstream(93). In fact, higher soluble
fibre intake is associated with lower plasma levels of the pro-
inflammatory cytokines IL-6(93,94).
Cohort studies and case–control studies. Several studies have
examined the relationship between whole grain food intake and
BC risk, but most analyses were focused on postmenopausal
women(95–97). Data regarding the association of fibres from
whole grains and BC are, however, inconsistent, probably due
to different effects from soluble v. insoluble fibres(98). In a large
cohort study, Cade et al.(99) evaluated the risk of developing BC
and consumption of dietary fibres, in pre- and postmenopausal
women. Data were collected from 35 792 women between 1995
and 1998 by using a postal questionnaire that included general
questions on diet. During 240 959 subject-years of follow-up, 350
postmenopausal and 257 premenopausal developed invasive
BC. In premenopausal, but not postmenopausal, women, a
statistically significant inverse relationship between total fibre
intake and risk of BC was found (RR 5th v. 1st quintile 0·48;
95 % CI 0·24, 0·96; P= 0·01). In particular, insoluble fibres from
cereals were inversely associated with risk of BC (P= 0·05)(99).
Farvid at al.(100) evaluated individual grain-containing foods
and whole and refined grain intake during adolescence, early
adulthood, and premenopausal years in relation to BC risk in
a population of 90 516 premenopausal women, within an age
range of 25 to 42 years, from the Nurses’ Health Study II.
During the 22 years of follow-up 3235 women developed inva-
sive BC. After adjustment for known BC risk factors, the authors
concluded that intake in both adulthood and adolescence of
whole-grain foods was associated with lower premenopausal
BC risk (highest v. lowest quintile: RR 0·82; 95 % CI 0·70, 0·97;
P= 0·03; RR 0·74; 95 % CI 0·56, 0·99; P= 0·09, respectively),
but not with postmenopausal BC risk. It is interesting to note that
these associations were mainly mediated by fibre intake in
general, while no single food or type of grain appeared to
account for these findings(100). However, Ferrari et al.(101) in a
cohort study, including 334 849 women, BC risk was inversely
associated with total dietary fibre intake (HR 5th v. 1st quintile
0·95; 95 % CI 0·89, 1·01; P= 0·03) and fibre from vegetables
(HR 5th v. 1st quintile 0·90; 95 % CI 0·84, 0·96; P< 0·01) but
not with fibre from fruit, cereals or legumes. In line with these
results, a case–control study conducted by Mourouti et al.(102)
investigating the risk of developing BC in relation to consump-
tion of whole grains in 250 cases and 250 controls evidenced that
the consumption of whole grain for more than seven times
per week was consistently associated with reduced risk of BC,
especially in premenopausal women, whereas no significant
association was observed in postmenopausal women. More
specifically, whole grain consumption of more than seven times
per week was associated with a 0·22-fold lesser risk of develop-
ing BC in premenopausal women (OR 0·22; 95 % CI 0·09, 0·54;
P= 0·001)(102). More recently, based on food frequency data
from a population-based case–control study including 2135 BC
cases in subjects of different ethnicity from the San Francisco
Bay Area Breast Cancer Study, Sangaramoorthy et al.(103) also re-
ported an association between dietary fibre intake and specific
BC subtypes defined by ER and PR status. In this study, the authors
confirmed that a high dietary intake of fibre-rich foods, such as
beans and grains, may lower the risk of BC in both pre- and
postmenopausal women. Of note, this study revealed a significant
association between high dietary fibre intake and the aggressive
BC subtype, such as ER– andPR–BC, forwhich few risk factors have
been identified, thus supporting the importance of non-oestrogen-
mediated mechanisms, for example, the IGF pathway(103).
Olive oil
Several studies have suggested that olive oil may be associated
with a decreased BC risk(104,105), even if such a relationship has
not been extensively studied in premenopausal women. The
main active components of olive oil, the major source of energy
in the MD, include monounsaturated lipids (especially oleic
acid), phenolic constituents such as hydroxytyrosol, tyrosol
(TY), glycoside-OL (oleuropein) and squalene(106). Data from
previous research studies attribute the anticancer effects of olive
oil to its high content in oleic acid, the main MUFA in olive oil. In
particular, oleic acid (18 : 1n-9) has been reported to suppress
the overexpression of HER-2/ErbB-2, a well-characterised onco-
gene playing a key role in the aetiology, invasive progression
and metastasis in several human cancers(107). As mentioned
above, olive oil is also an important reservoir of polyphenolic
compounds, which are widely known for their anticancer
properties. In particular, OL, 3,4-dihydroxyphenylethanol (HT)
and TY(108,109) are potent antioxidants able to scavenge the
superoxide anion, H2O2 and hypochlorous acid(110). Phenolic
compounds also possess anti-atherogenic, anti-thrombotic and
anti-inflammatory properties(111,112). Han et al.(113) demonstrated
that HT andOL, at the dosage of 0·1 %, were able to decrease cell
viability, inhibit cell proliferation and induce cell apoptosis in
MCF-7 cells, with an increase in the number of cells in the
G0/G1 phase. Moreover, olive oil polyphenols are able to inter-
act with the NF-κB signalling pathway, which plays a pivotal role
in the inflammatory response of the organism and represents an
important target for preventing inflammation(114). Briefly, the
induction by any inflammatory stimulus of cyclo-oxygenase
(COX)-2 gene, the master switch that activates the inflammatory
response, is a prominent feature of all stages of BC(115–117). COX-
2 induction quickly results in the biosynthesis of prostaglandins
of the E-series, particularly PGE2, which in turn orchestrate the
inflammatory response. Amplification of the COX-2 inflamma-
tory cascade is triggered by recognition of proinflammatory
stimuli by toll-like receptors on the cell membranes of exposed
cells and activation of NF-κB, thereby initiating the production of
cytokines, such as TNF-α, IL-1, IL-6 and IL-17, prostaglandins,
chemokines and adhesion molecules(118). In an in vitro study,
Scoditti et al.(119) studied the effects of antioxidant polyphenols
from virgin olive oil (OL and HT) on the angiogenic response in
human vascular endothelial cells. The results of this study
supported the potential protective role for dietary polyphenols
in cancer as the authors reported a decreased angiogenesis
via the inhibition of matrix metallopeptidase-9 (MM-9) and
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COX-2, in association with a significant reduction in the
stimulated intracellular ROS levels and in the activation of the
redox-sensitive NF-κB(119).
Cohort studies and case–control studies. The largest case–
control study providing data on BC risk and olive oil intake is
an Italian investigation of 2569 cases and 2588 controls. In this
study, La Vecchia et al.(120) examined the intake of olive oil
and other dietary fats by FFQ. The OR for subsequent quintiles
of olive oil intake compared with the lowest one were 1·05 (95 %
CI 0·9, 1·3), 0·99 (95 % CI 0·8, 1·2), 0·93 (95 % CI 0·7, 1·2) and
0·87 (95 % CI 0·7, 1·1; P= 0·08); however, no substantial
differences were observed between pre- and postmenopausal
women(120). Subsequently, in a case–control study, Garcia-
Segovia et al.(105) evaluated the risk of developing BC in relation
to consumption of monounsaturated fat, in pre- and postmeno-
pausal women. The study included a total of 755 women: 291
incident cases with confirmed BC and 464 controls randomly
selected from the Canary Island Nutrition Survey (ENCA).
Data regarding the usual dietary patterns were collected by using
FFQ, and the results supported the protective role of olive oil
consumption on BC in Canary Islands women (OR 5th v. 1st
quintile 0·27; 95 % CI 0·17, 0·42; P= 0·07), but the authors did
not investigate the differences related to menopausal status(105).
Furthermore, an increased risk of BCwas shown to be associated
with higher mammographic density(121–123), and, currently, it is
proposed as an intermediate phenotype for identifying women
with a higher risk of BC(124,125). In a cross-sectional study, García-
Arenzana et al.(126) assessed the association between mammo-
graphic density and diet among 3548 pre- and postmenopausal
women extracted from seven BC screening programmes in
Spain. The results showed that an increase in olive oil consump-
tion of two tablespoons per d (22 g) was associated with a lower
mammographic density (OR 0·72; 95 % CI 0·56, 0·93; P= 0·008),
with no differences concerning menopausal status(126).
Fish
Some studies indicate the existence of an inverse association
between high intake of fish food and BC risk(127,128), but again
most analyses were focused on postmenopausal women(129).
The protective effect of the consumption of seafood is mainly
due to the high content of n-3 PUFA. α-Linolenic acid
(18 : 3n-3) is the precursor of the n-3 PUFA family, which can be
further elongated and desaturated to two important long-chain
n-3 PUFA: EPA (20 : 5n-3) andDHA (22 : 6n-3)(130). These classes
of PUFA inhibit mammary carcinogenesis at all stages of cancer:
initiation(131), promotion(132) and progression(133), in both in vitro
and animal studies. One of the key cellular functions of PUFA in
reducing tumour development is the inhibition of the synthesis
of inflammatory eicosanoids derived from arachidonic acid
(AA)(134). In fact, higher intakes of α-linolenic acid reduce the
synthesis of AA from linoleic acid (18 : 2n-6) and, thus, less
AA is available for the synthesis of inflammatory eicosa-
noids(135,136). Moreover, EPA also has other complementary
actions on COX-2, as it displaces AA as an enzymic substrate
of COX-2 and decreases expression of COX-2(137), thus limiting
the rate of PGE2 synthesis(138,139).
Cohort studies and case–control studies. In a case–control
study, Goodstine et al.(140) investigated the association between
the intake of n-3 and other fatty acids and the n-3:n-6 PUFA ratio
and BC risk. In premenopausal women, the consumption of the
lowest ratio of n-6 to n-3 was associated with a non-statistically
significant 41 % reduction of BC risk (OR 0·59, 95 % CI 0·29, 1·19;
P= 0·09)(140). In a subsequently case–control study, Kim
et al.(141) confirmed these data. The authors investigated the
association between fish intake and the incidence of BC in
Korean women in 362 patients with incident BC, within an
age range of 25 to 77 years. Premenopausal women revealed
a significant reduction in BC risk for the highest intake quartiles
of n-3 fatty acids (OR 4th v. 1st quartile 0·46; 95 % CI 0·22, 0·96),
compared with the lowest quartile taken as reference group(141).
In the Japan cohort study, a significant decrease in the risk of BC
was detected in women with the highest dietary intake of fish fat
and long-chain n-3 PUFA. In this study, Wakai et al.(142) exam-
ined 26 291 women within an age range of 40 to 79 years,
who completed a questionnaire on dietary and other factors.
During the period of 7·6 years of follow-up 129 incident cases
of BC were documented. A significant decrease in risk was
detected for the highest quartile of intake compared with the
lowest quartile for fish fat and long-chain n-3 fatty acids intake;
the RRwere 0·56 (95 % CI 0·33, 0·94; P= 0·034) and 0·50 (95 % CI
0·30, 0·85; P= 0·042), respectively. For premenopausal women
at baseline, the RR for the higher quartiles of long-chain n-3 fatty
acids were lesser than 1, but far from significant levels(142).
Similar results were found in another cohort study, where
Murff et al.(143) investigated the association of dietary PUFA
and the ratio of n-6 PUFA:marine-derived n-3 PUFAwith BC risk
in the Shanghai Women’s Health Study. The authors determined
dietary fatty acid and fish intake by using FFQ. This study
showed no association between n-3 PUFA intake and BC risk,
while a low n-3 PUFA intake in women who had the highest
n-6 PUFA was positively correlated with an elevated BC risk.
These studies indicated the necessity of highern-3 PUFA intakes,
n-6 intakes being generally adequate in all populations, and thus
emphasising the potential value of n-3 PUFA as effective agents
against BC. No significant differences in individual PUFA effect
were observed between pre- and postmenopausal women(143).
Moderate red wine drinking
Alcohol consumption, including wine, has been consistently
associated not only with an increased risk of BC(144–146), but also
with breast density in both pre- and postmenopausalwomen(147–149).
The mammary epithelium expresses class I alcohol dehydro-
genase and the tissue may be susceptible to an intermediate
metabolite of ethanol oxidation (acetaldehyde), responsible
for DNA damage and activation of the Fantoni anaemia-BC sus-
ceptibility (FA-BRCA)(144,150). Marietta et al.(151), in fact, recently
showed that the exposure of human cells to acetaldehyde
resulted in activation of the FA-BRCA network, as indicated by
increased FANCD2 mono-ubiquitination and phosphorylation
of BRCA1. Consistent with a DNA damage response, acetalde-
hyde generates several different types of DNA adducts that can
block DNA replication in humans(152). However, considering
the healthy effects of red wine in the prevention and treatment
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of several chronic diseases(153), it is questionable whether also a
moderate intake red wine could raise the risk of BC
(WCRF)(23). Indeed, red wine is rich in phenolic compounds,
such as resveratrol, which exert anti-inflammatory and antioxi-
dant effects and could act as protective factors in BC develop-
ment(154). Resveratol is a natural polyphenol present in fruit
with red skins, including grapes, and it is therefore also present
in high concentration in wine, especially red wine. Resveratrol is
also involved in the activation of the protein SIRT1, an enzyme
that is a member of the sirtuin family of proteins, which is
capable of regulating the activity of certain transcription genes
that are involved in the regulation of appetite(155). Thus, SIRT1
affects the regulation of energy balance, which in turn can aid
in the prevention of diet-dependent obesity and related
metabolic disorders(155). Also, resveratrol plays a key role in
the prevention of cancer by blocking the process of initiation,
promotion and progression(155). As a phyto-oestrogen, it regu-
lates the expression of numerous genes associated with the
development of BC, including a tumour suppressor BRCA1
gene(156). Phytochemicals could also account for different poten-
tial mechanistic pathways as red wine is also endowed with
anti-oestrogenic activity(157) and may serve as a nutritional
aromatase inhibitor(153). Nonetheless, the protective role of
moderate quantities of red wine at meals for reducing BC risks
remains questionable.
Cohort studies and case–control studies. In a cross-over study
conducted in healthy premenopausal women, Shufelt et al.(153)
compared red wine and white wine consumption and showed
that red wine was associated with significantly lower levels of
total and free testosterone and sex hormone-binding globulin,
as well as a significantly higher levels of luteinising hormone,
although without significant differences in oestradiol levels. In
a case–control study in Southern France, Bessaoud &
Daures(158) evaluated the effects of drinking patterns of alcoholic
beverages onBC risk, focusing onwine consumption in particular.
The study reported a lower risk of BC among women consuming
10–12 g/d of wine (OR 0·51; 95% CI 0·30, 0·97) when compared
with non-wine drinkers, but they did not evaluate red and white
wine separately, or the difference of risk between pre- and post-
menopausal women(158). Nevertheless, in a cohort study,
Fagherazzi et al.(159) evaluated the interaction between alcohol
intake and BC risk in pre- and postmenopausal women. This study
showed a positive trend in BC risk with increasing alcohol intake
in the overall population (Ptrend= 0·0003), and women who
consumed more than two standard drinks per d had a significant
19% increase in risk (HR 1·19; 95 % CI 1·04, 1·36), but, this
association was limited to postmenopausal women (Ptrend < 0·0001
and HR 1·24; 95% CI 1·07, 1·44)(159).
Red meat
It is known that processed or cooked red meat is a source of
carcinogens, due to the generation of heterocyclic amines,
N-nitroso compounds and polycyclic aromatic hydrocarbons
generated during high-temperature cooking, which are respon-
sible for an increase in BC risk in humans, as demonstrated in
numerous in vitro and in vivo test systems(160). In particular,
heterocyclic amines display oestrogenic activity and breast
tissue-specific carcinogenic activity has been reported(161). In
addition, several studies have suggested that induction of lipid
peroxidation mediated by free radicals of the fats found in red
and processed meats could be another mechanism by which
processed red meat may promote carcinogenesis(162,163).
Cohort studies and case–control studies. Several studies have
investigated the relationship between intake of redmeat and risk
of BC in premenopausal women(164,165). In a prospective study,
Linos et al.(164) investigated red meat intake during adolescence
and BC incidence in a group of 39 268 premenopausal women,
within an age range of 25 to 43 years. During a 7-year follow-up,
455 women developed invasive BC(164). Women who consumed
the greatest quantity of red meat during high school had a 30 to
40 % higher risk of BC as compared with women with the lowest
intake of red meat (RR 5th v. 1st quintile 1·34; 95 % CI 0·94, 1·89;
P= 0·05). A significant linear association was observed with
every additional 100 g of red meat consumed per d (RR 1·20;
95 % CI 1·00, 1·43; P= 0·05). Furthermore, this association was
more pronounced in ER-positive subjects (RR 1·36; 95 % CI
1·08, 1·70; P= 0·008) and was not significant in ER-negative
women (RR 0·99; 95 % CI 0·61, 1·61; P= 0·97)(164). Later, these
results were confirmed by Farvid et al.(166) in a population study.
The authors investigated the consumption of red meat during
adolescence as related to BC risk in the Nurses’ Health Study
II cohort(166). The cohort consisted of a total of 116 430 females
that completed an FFQ about their diet while in high school.
During a 13-year follow-up, 1132 new cases of BC were docu-
mented. In this study a greater consumption of total red meat
was significantly associated with a higher risk of premenopausal
BC (RR 5th v. 1st quintile 1·42; 95 % CI 1·05, 1·94; P= 0·007),
contrary to what was observed in postmenopausal BC(166). In
line with these results, in a very recent prospective study,
Diallo et al.(167) evaluated the prospective associations between
red and processed meat intakes and overall, breast and prostate
cancer risk. The study included 61 476 men and women with
an age of at least 35 years who completed three 24 h dietary
records during the first years of follow-up. During the follow-
up 1609 incident cancer cases were diagnosed, among which
544 BC. Red meat intake was associated with increased overall
cancer risk (HR 5th v. 1st quintile 1·31; 95 % CI 1·10, 1·55;
P= 0·01) and increased BC risk (HR 5th v. 1st quintile 1·83;
95 % CI 1·33, 2·51; P= 0·002). This association between redmeat
intake and increased BC risk was observed in both premeno-
pausal women (HR 5th v. 1st quintile 2·04; 95 % CI 1·03, 4·06)
and postmenopausal women (HR 5th v. 1st quintile 1·79; 95 %
CI 1·26, 2·55)(167).
Nuts
Nuts are a rich source of nutrients, such as PUFA, proteins, fibres,
vitamins, minerals, antioxidants and phytochemicals, including
phenolic compounds and phytosterols(168). The multiple
mechanisms of the anti-tumoural effect of these components
are related to their antioxidant activity, regulation of cell
differentiation and proliferation, reduction of tumour initiation
or promotion, repair of DNA damage, anti-inflammatory effects,
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immunoregulatory activity, induction or inhibition of metabolic
enzymes and hormonal mechanisms(169,170).
Cohort studies and case–control studies. The evidence of nut
intake and BC risk is only limited and focused on postmeno-
pausal women(171). Extrapolating data from the above-
mentioned cohort study by Farvid et al.(166) on adolescent
meat intake and BC risk, the authors found that there was no
significant association between adolescent intake of nuts and
premenopausal BC. In a case–control study, Liu et al.(172) inves-
tigated the associations of dietary fibres, vegetable proteins,
vegetable fat and nuts consumed during adolescence with adult
BC risk (OR 5th v. 1st quintile 0·76; 95 % CI 0·61, 0·95 for > serv-
ing/d v. < 1 serving/month intake; P= 0·04). The study included
2865 cases and 3299 controls who furnished information on their
diet habits during adolescence through an FFQ(172). The results
showed that nut intake during adolescence was inversely
associated with BC risk. These results were comparable in
pre- and postmenopausal BC(172).
Legumes
Some studies indicate the existence of an inverse association
between high intake of legumes and BC risk. However, consid-
ering the limited number of studies it was not possible to conduct
analyses according to menopausal status(34,173). As reported
above, the protective effect of legumes is attributable to their
high content of fibres, in particular soluble fibres. In addition,
lignans and phytic acid from legumes have shown antioxidative
and anticarcinogenic potential(174).
Cohort studies and case–control studies. In a case–control
study, Sangaramoorthy et al.(103) evaluated the risk of developing
BC and consumption of dietary bean fibre in pre- and postmeno-
pausal women. Data were collected from 17 581 women aged
35–79 years and newly diagnosed with a first primary invasive
BC by using a FFQ that included general questions on diet
and on fibre intake. The authors reported that there was a 20 %
reduction in BC riskwith high intake (high v. low quartile) of bean
fibre (Ptrend= 0·01), total beans (Ptrend= 0·03) or total grains
(Ptrend= 0·05). Inverse associations were strongest for ER–/PR–
BC, with a risk reduction associatedwith high intake ranging from
28 to 36%, without differences in pre- and postmenopausal
women(103). In the Nurses’ Health Study, Adebamowo et al.(175)
evaluated the risk of developing BC and consumption of flavo-
nol‐rich foods intake in premenopausal women, aged between
26 and 46 years. Among the major food sources of flavonols, a
significant inverse association with the intake of beans or lentils
has been reported. The multivariate RR, comparing the highest
category (or more times per week) of cumulative average beans
or lentils intake with the lowest category (less than once per
month), was 0·76 (95 %CI 0·57, 1·00; P for test of trend= 0·03)(175).
Conclusions
Diet is a modifiable factor risk for BC and several studies have
reported that low intake of vegetables and fruit and high
consumption of red and processed meat increase the risk of
developing BC. Epidemiological studies indicate an increase in
cases of BC in a younger age at diagnosis. Premenopausal BC
is also highly associated with a significantly increased risk of
cancer recurrence and higher mortality rate. Despite there being
a growing interest in preventive strategies to tackle the increasing
rate of premenopausal BC incidence, the role of the MD and its
main components in premenopausal women has not yet been
sufficiently investigated. Prospective cohort and case–control
studies suggested that high adherence to a diet based on the
MD pattern, rich in n-3 PUFA, fruits, vegetables, fibres, in associ-
ation with a reduced intake of red meat and a moderate red wine
consumption, gives a significant protection against incidence of
BC in postmenopausal women. The protective effects of the
MDmight be due to several mechanisms, involving the regulation
of cell proliferation, induction of apoptosis, and antioxidant
action. Although limited by several methodological biases that
might potentially affect or influence the interpretation of the find-
ings, including sampling methodology and characteristics of the
population included, the studies included in the present review
indicate that currently there is no sufficient scientific evidence
to support that adherence to the MD pattern is associated with
a decrease in BC risk or with specific BC characteristics in
premenopausal women. This evidence is in striking contrast to
the well-known anti-cancer effects of the MD. Nevertheless,
focusing separately on the effects of the main components of
the MD, there is an overall agreement that in premenopausal
women a high total fruit intake, as well as the intake of insoluble
fibres, the regular consumption of whole grains or the intake of
nuts, especially during adolescence, are consistently associated
with a reduced risk of BC, whereas a high consumption of red
meat during adolescence is associated with a high risk of BC.
On the contrary, an increase in olive oil and PUFA-rich food
consumption, such as fish, and moderate red wine consumption
are associated with a lower risk of BC, but without differences
concerning menopausal status. On these bases, the clinical and
experimental evidence reported in the present review underlines
that an accurate nutritional counselling based on healthy dietary
choices and lifestyle modifications should be an integral part of
the management of premenopausal women with BC and might
be of strategic relevance in terms of the prevention of BC.
These recommendations should become part of a normal lifestyle
during early childhood, when the mammary glands may be
particularly vulnerable to breast carcinogenesis due to rapid
proliferation of cells and lack of terminal differentiation.
However, long-term studies are needed to further confirm
the beneficial effect of the MD and of its components in the
prevention of BC in premenopausal women.
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